Definitive Contract FA282318C6022
Award Date 6/1/18
Potential Completion Date 5/31/21
Potential Value $227K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a $203,082.53 delivery order to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in New Jersey. The contract is for the drop shipment of reagents, with a CPT lease/maintenance component. The contract was awarded by the Defense Health Agency, a defense agency, on September 28, 2020, with a completion date of December 31, 2020. It is a firm fixed-price contract and does not utilize any set-aside designations. Ortho-Clinical...
- This is a delivery order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The $186,396.12 firm fixed-price contract is for the delivery of ortho-clinical reagents and consumables, including CPT lease and maintenance, with an ultimate completion date of December 31, 2020. The contract is not set aside and was awarded under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule,...
- This is a delivery order awarded by the Defense Medical Command (MEDCOM) to Ortho-Clinical Diagnostics Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture. The $180,827.94 firm fixed-price contract is for the provision of in vitro diagnostic reagents and test kits, with a period of performance ending on September 30, 2017. This award is part of a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle that Ortho-Clinical Diagnostics holds...
- The U.S. Air Force Test Center awarded a $206,754.50 firm fixed-price purchase order to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of unspecified products and services. The award does not have a set-aside designation and is set to expire on May 31, 2023. Ortho-Clinical Diagnostics is a vendor on several indefinite-delivery/indefinite-quantity (IDIQ) contracts with various federal agencies, including the Department of Veterans Affairs,...
- This is a firm fixed-price delivery order awarded by the Pacific Air Forces, a defense agency, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $245,091.72 contract is for monthly reagents and maintenance services, as well as annual reagents and services, for Ortho Vision blood analyzers. The contract has an ultimate completion date of February 27, 2026 and was awarded on February 28, 2023. It is not associated with a set-aside program. Ortho-Clinical...
- This federal contract award was issued to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturer and supplier, by the Defense Health Agency (DHA) for the procurement of in vitro diagnostic reagents and test kits. The award, valued at $250,000.00, is a firm fixed price delivery order contract with a period of performance ending on September 30, 2020. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone joint venture that specializes in providing a wide...
- This federal contract award is for the delivery of reagents and consumables to the Defense Health Agency, a defense agency. The $186,396.12 firm fixed-price delivery order contract was awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer based in Raritan, New Jersey. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. provides advanced diagnostic solutions, including blood bank analyzers, clinical...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on July 11, 2025, by the Medical Supply Chain division of the Department of Defense for the supply of Anti-A Bioclone 15x10ml reagents, valued at $1,156.61. The contract employs fixed-price pricing with economic price adjustment provisions and is scheduled for ultimate completion by August 1, 2025. The work will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used in this...
- This federal contract was awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company that provides a wide range of diagnostic solutions. The contract, valued at $83,634.46, is for the delivery of ortho clinical reagents to the U.S. Air Force's Air Combat Command. The contract has a completion date of September 29, 2025 and is a Delivery Order under a larger contract vehicle. No set-aside designation was used for this award. Ortho-Clinical Diagnostics, Inc. has...
- This federal contract award was made by the Defense Health Agency (DHA) to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturer, for REAGENTS AND PERIPHERAL services. The $60,000.00 firm fixed price award has an ultimate completion date of September 30, 2016 and did not utilize a set-aside designation. Ortho-Clinical Diagnostics Inc. is a for-profit organization and self-certified HUBZone joint venture that has received numerous federal contract awards and indefinite delivery...